Introduction {#sec1-1}
============

Lung cancer referred as one of the major concerns in the worldwide. According to the increasing number of lung cancer, it seems necessary to find novel therapeutics from natural sources that can potently inhibit or kill cancer cells.\[[@ref1]\] Snake venom contains various proteins and peptides with pharmacological and physiological properties.\[[@ref2]\] Snake venom causes disruptions in breathing, weakness, drowsiness, cardiogenic shock, respiratory disorders, and ultimately death. Therapeutic drugs such as antihypertension, antistroke, and anticoagulant have been evaluated from snake venom.\[[@ref3][@ref4][@ref5]\] Snake venom consists of proteins including disintegrins, metalloproteinases, phospholipases, serine proteases, and C-type lectins.\[[@ref6]\] The C-type proteins in snake venom have a binding region for calcium and sugar. However, in snake venom, there is also C-type lectins such as proteins named snaclecs which do not have binding region for calcium and sugar.\[[@ref7]\] Snaclecs are heterodimers with 25 kDa consisting of αβ units covalently linked together with disulphide bond.\[[@ref8]\] They act as potent inhibitors of αvβ3 and α5β1 integrins, tumor invasion, adhesion, migration, proliferation, and angiogenesis.\[[@ref9]\] They also known as antiplatelet proteins and resulted in blockade of Von Willebrand factor.\[[@ref10]\] The inhibitory effect of snaclecs on adhesion of different cancer cell lines has been evaluated.\[[@ref7][@ref9]\] Application of snake venom has been evaluated in ancient medicine for increasing life span.\[[@ref1]\] Thus, snake venom was used in homeopathic medicine. Snake venom of *Vipera lebetina turanica* showed chemotherapeutic potency through induction of apoptosis in prostate cancer,\[[@ref5]\] neuroblastoma cells,\[[@ref11]\] and colon cancer cells.\[[@ref12]\] In this study, for the first time, we evaluated cytotoxic and antiadhesive effects of Iranian *V. lebetina turanica* crude venom and fractions on lung epithelial tumor cells (TC-1).

Materials and Methods {#sec1-2}
=====================

*V. lebetina* snake venom was collected in Serpentarium of Pasteur Institute of Iran, Tehran, Iran. TC-1 lung epithelial tumor cell line (ATCC: CRL-2785) was purchased from Iranian National Cell Bank. TC-1 cell was cultured in RPMI 1640 medium (Sigma, USA) supplemented by 10% inactivated fetal bovine serum (FBS) (Gibco, USA), penicillin 100U/ml, and streptomycin 100 μg/ml (Gibco, USA) and incubated at 37°C in humidified atmosphere containing 5% CO~2~.

*Vipera lebetina* snake venom fractionating {#sec2-1}
-------------------------------------------

About 50 mg of lyophilized venom of *V. lebetina* was dissolved in 500 μl of 20 mM ammonium acetate, pH 6.8 and loaded on Sephacryl S-200 hr column (GE Healthcare, Biosciences). The column was equilibrated with 20 mM ammonium acetate, pH 6.8. The elution of fractions was performed using flow rate of 1 ml/min. All the fractions were pooled separately and lyophilized. The protein concentration was determined by the BCA protein assay kit according to the manufacturer\'s instruction (Pierce Rochford, USA). All eluted fractions evaluated using SDS-PAGE 15% under reducing condition.

Cytotoxicity assay {#sec2-2}
------------------

Cytotoxicity effect of *V. lebetina* on TC-1 cells was evaluated using 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. About 1.5 × 10^5^ cells seeded in 96-well plate containing 200 μl RPMI 1640, penicillin 100U/ml, streptomycin 100 μg/ml, and FBS 10% and incubated at 37°C and 5% CO~2~ for 24 h. Then, cells were treated with various concentrations of *V. lebetina* crude venom and fractions (0--200 μg/ml). After 24-h incubation at same culture condition, 20 μl of MTT solution (5 mg/ml of PBS) (Sigma) added to each well, and plate incubated in dark at 37°C. After 4-h incubation, 100 μl DMSO (dimethyl sulfoxide) (Sinaclon, Bioscience) added to the wells, and absorbance was measured at 570 nm using spectrophotometer (Epoch, Bio Tek, USA).

Adhesion assay {#sec2-3}
--------------

About 2 × 10^4^ TC-1 cells with RPMI 1640 medium supplemented by 10% FBS were cultured in 96-well plate with or without different concentration of fractions 2 and 5 (0--200 μg/ml), and plate incubated for 1 h at 37°C and 5% CO~2~. Then, the cells in supernatant of wells collected, centrifuged at 900 g for 1 min, counted and defined as nonadhesive cells. The adhesive cells also trypsinized, counted and defined as adhesive cells. The assay was performed triplicate.

Results {#sec1-3}
=======

Purification results {#sec2-4}
--------------------

Snake venom of *V. lebetina* was fractionated by fast protein liquid chromatography (FPLC). The fractions chromatogram is shown in [Figure 1](#F1){ref-type="fig"}. As it can be seen, six fractions isolated using S-200 column. The purity and component of pooled fractions were evaluated by SDS-PAGE under reducing condition \[[Figure 2](#F2){ref-type="fig"}\].

![Fast protein liquid chromatography. Crude venom of *Macrovipera lebetina* fractionated using fast protein liquid chromatography on Sephacryl S-200 hr column. Six individual fractions detected. Fractions 2 and 5 selected for further analysis](JFMPC-6-780-g001){#F1}

![Reducing 15% SDS-PAGE M; Protein marker (the MW of marker lanes from bottom to top was 10, 15, 25, 35, 40, and 55 kDa), lane 1; fraction 1, lane 2; fraction 2, lane 3; fraction 3, lane 4; fraction 4, lane 5; fraction 5, lane 6; and fraction 6](JFMPC-6-780-g002){#F2}

Cytotoxicity results {#sec2-5}
--------------------

Cytotoxicity effect of *V. lebetina* venom was evaluated by MTT assay. Our results demonstrated inhibitory and cytotoxic effect of *V. lebetina* venom on TC-1 cells in dose-dependent manner \[[Figure 3](#F3){ref-type="fig"}\]. The achieved IC50s were 16.5, 19.5, 6, 53, 25, 7.3, and 59 μg/ml for *V. lebetina* crude venom, fraction 1, fraction 2, fraction 3, fraction 4, fraction 5, and fraction 6, respectively. According to the results, fractions 2 and 5 showed high cytotoxic effect on proliferation of TC-1 cells. Therefore, fractions 2 and 5 selected for further analysis using antiadhesion assay.

![MTT assay results. antiproliferative and cytotoxic effect of *V. lebetina* venom were evaluated by MTT assay. IC50s calculated for each fraction and also crude venom. The assay was performed in triplicate, a) Crud venom, b) F1, c) F2, d) F3, e) F4, f) F5 and g) F6](JFMPC-6-780-g003){#F3}

Adhesion assay results {#sec2-6}
----------------------

It has been demonstrated that in snake venom, there are potential anticancer agents with antiadhesion effect.\[[@ref1]\] With that aim, we used fractions 2 and 5 (according to their high cytotoxicity effect) to evaluate their effect on adhesion of TC-1 cells to culture flask. Our results revealed that both fractions 2 and 5 had dose-dependent effect on TC-1 adhesion. However, this effect was different among fractions 2 and 5 \[[Figure 4](#F4){ref-type="fig"}\]. In lower concentration of fractions 2 and 5, most of cells were adherent and low number of cells detected in supernatant (nonadhesive cells).

![Adhesion assay analysis of F2 (a) and F5 (b). As can be seen, anti-adhesive effect of F2 an F5 were higher in high fraction concentration.](JFMPC-6-780-g004){#F4}

Discussion {#sec1-4}
==========

Here, we evaluated the cytotoxic effect of *V. lebetina* venom on TC-1 cells. Our results showed that *V. lebetina* crude venom had cytotoxic effect on TC-1 cells in dose-dependent manner and with increasing the venom concentration almost all cells died. Indeed, we showed fractions 2 and 5 of *V. lebetina* inhibited adhesion of TC-1 lung cancer cells *in vitro*. We also showed that this effect was dose dependent, and in higher concentration of venom fractions, more cells detected as nonadhesive. Our results are consistent with study of Jebali *et al*.\[[@ref13]\] that showed snake venom could inhibit MDA-MB-231 cells proliferation and adhesion. In other study, Sarray *et al*. showed that snake venom could inhibit adhesion of human TC-1,\[[@ref7]\] and our achieved results were consistent with their achievement. It has been believed that such effect is related to C-type lectin proteins.\[[@ref7][@ref9]\] Indeed, C-type lectin proteins have shown many antitumor effects,\[[@ref14]\] with *in vivo* and *in vitro* antiangiogenesis activity.\[[@ref15]\] C-type lectin proteins inhibit collagen receptor α2β1 and thereby, interfere with integrin activity.\[[@ref9]\] Integrins are responsible for development of diseases such as cancer. Therefore, inhibiting integrin activity could be as possible therapies.\[[@ref9]\]

Current studies in our laboratory focused on finding and development of potential molecules with therapeutic activity from snack or scorpion or other animal venoms and toxins. For this aim, we prepared snake venom toxin of *V. lebetina* and fractionated using Sephacryl S-200 hr column.\[[@ref13]\] To the best of our knowledge, this is the first report describing cytotoxic and antiadhesive effect of Iranian *V. lebetina* venom on lung epithelial cancer cell line (TC-1). The cytotoxic effect of *V. lebetina* venom on human umbilical vein endothelial cells (HUVECs) cells evaluated by Kakanj *et al*.\[[@ref16]\] Kakaj *et al*. in their study showed that *V. lebetina* crude venom had cytotoxic effect on HUVECs and inhibited HUVECs proliferation in dose-dependent manner.\[[@ref16]\] Our study is consistent with Kakanj *et al*. study. However, we analyzed antiadhesive effect of *V. lebetina* venom on TC-1 cells. However, further analysis is going to evaluate *V. lebetina* effect on other cell lines.

Conclusion {#sec1-5}
==========

We described the purification of snake venom of *V. lebetina* by FPLC and demonstrated the antiadhesive activity of snake venom toxin of *V. lebetina* on lung epithelial cancer cell line (TC-1). The results promise as novel therapeutics development from *V. lebetina* venom.
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